Details of the Drug-Related molecule(s) Interaction Atlas

General Information of DTT (ID: TTYGQ8A)

DTT Name	Dual-specificity tyrosine-phosphorylation regulated kinase 1B (DYRK1B) DTT Info
Gene Name	DYRK1B

Molecule-Related Drug & Molecule List

Molecule-Related Drug List

Molecule Type:

DTT

DTP

DME

Drug Status:

Patented Agent(s)

Investigative Drug(s)

Download the Complete Related Drug List

18 Patented Agent(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
PMID28766366-Compound-Scheme14BINDY	DMBQ0RN	N. A.	N. A.	Patented	[1]
PMID28766366-Compound-Scheme21Left	DMWTRUK	N. A.	N. A.	Patented	[1]
PMID28766366-Compound-Scheme21Right	DMF3X40	N. A.	N. A.	Patented	[1]
PMID28766366-Compound-Scheme25-2	DM7OGWH	N. A.	N. A.	Patented	[1]
PMID28766366-Compound-Scheme25-3	DMGVT5Y	N. A.	N. A.	Patented	[1]
PMID28766366-Compound-Scheme25-4	DMOD9BY	N. A.	N. A.	Patented	[1]
PMID28766366-Compound-Scheme2WO2012/098065bottom	DMO4Q95	N. A.	N. A.	Patented	[1]
PMID28766366-Compound-Scheme2WO2012/098065upper	DMVJDRI	N. A.	N. A.	Patented	[1]
PMID28766366-Compound-Scheme4Bottom	DMDXIU9	N. A.	N. A.	Patented	[1]
PMID28766366-Compound-Scheme4Upper	DMPH4JV	N. A.	N. A.	Patented	[1]
PMID28766366-Compound-Scheme5	DMO6KZ5	N. A.	N. A.	Patented	[1]
PMID28766366-Compound-Scheme7WO2012/098070bottom	DMQV6R0	N. A.	N. A.	Patented	[1]
PMID28766366-Compound-Scheme7WO2012/098070upper	DMGAQR5	N. A.	N. A.	Patented	[1]
PMID28766366-Compound-Scheme9EHT1610	DMMZGC8	N. A.	N. A.	Patented	[1]
PMID28766366-Compound-Scheme9EHT3356	DMVBPML	N. A.	N. A.	Patented	[1]
PMID28766366-Compound-Scheme9EHT5372	DM0O18N	N. A.	N. A.	Patented	[1]
PMID28766366-Compound-Scheme9EHT6840	DMVY6PX	N. A.	N. A.	Patented	[1]
PMID28766366-Compound-Scheme9EHT9851	DM7RPKM	N. A.	N. A.	Patented	[1]
------------------------------------------------------------------------------------


⏷ Show the Full List of 18 Patented Agent(s)

3 Investigative Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
PMID23642479C17	DM4JWMA	Discovery agent	N.A.	Investigative	[2]
PMID24900699C68	DM2V4MJ	Discovery agent	N.A.	Investigative	[3]
WO2013026806C72	DM21WOP	Discovery agent	N.A.	Investigative	[4]
------------------------------------------------------------------------------------

Molecule Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

References

1	Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors: a survey of recent patent literature.Expert Opin Ther Pat. 2017 Nov;27(11):1183-1199.
2	Small-molecule pyrimidine inhibitors of the cdc2-like (Clk) and dual specificity tyrosine phosphorylation-regulated (Dyrk) kinases: development of chemical probe ML315. Bioorg Med Chem Lett. 2013 Jun15;23(12):3654-61.
3	Tricyclic Pyrimidines As Inhibitors of DYRK1A/DYRK1B As Potential Treatment for Down's Syndrome or Alzheimer's Disease. ACS Med Chem Lett. 2013 Apr 26;4(6):502-3.
4	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2010).